Kinoxis Therapeutics
PrivateLast Round
Grant
Dec 23, 2024
Total Funding Raised
$22.37M
Company Overview
Kinoxis Therapeutics is a biotechnology company developing novel small-molecule therapies for the treatment of neuropsychiatric disorders, including substance use disorders, agitation, and aggression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kinoxis Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Kinoxis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 23, 2024 | ||||
| Series B | Aug 12, 2024 | ||||
| Grant | Jun 8, 2023 | ||||
| VC Round | Dec 22, 2020 | ||||
| Grant | Sep 29, 2019 | ||||
Series A | Feb 15, 2018 |
Key People
Founding team and executive leadership
Kinoxis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| CUREator | Grant |
| NIH RADx | Grant |
| UniSuper Management | Series B |
| Avicella Capital | Series B |
| National Institutes of Health (NIH) | Grant |
| Uniseed | VC Round, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 107% MoM, reaching 505.
- Jun 8, 2023
Received $4M from National Institute on Drug Abuse and NIH.
Kinoxis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kinoxis Therapeutics's valuation, stock price, and market status.